227 related articles for article (PubMed ID: 34112699)
1. Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.
Horak P; Heining C; Kreutzfeldt S; Hutter B; Mock A; Hüllein J; Fröhlich M; Uhrig S; Jahn A; Rump A; Gieldon L; Möhrmann L; Hanf D; Teleanu V; Heilig CE; Lipka DB; Allgäuer M; Ruhnke L; Laßmann A; Endris V; Neumann O; Penzel R; Beck K; Richter D; Winter U; Wolf S; Pfütze K; Geörg C; Meißburger B; Buchhalter I; Augustin M; Aulitzky WE; Hohenberger P; Kroiss M; Schirmacher P; Schlenk RF; Keilholz U; Klauschen F; Folprecht G; Bauer S; Siveke JT; Brandts CH; Kindler T; Boerries M; Illert AL; von Bubnoff N; Jost PJ; Spiekermann K; Bitzer M; Schulze-Osthoff K; von Kalle C; Klink B; Brors B; Stenzinger A; Schröck E; Hübschmann D; Weichert W; Glimm H; Fröhling S
Cancer Discov; 2021 Nov; 11(11):2780-2795. PubMed ID: 34112699
[TBL] [Abstract][Full Text] [Related]
2. Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma.
Byron SA; Tran NL; Halperin RF; Phillips JJ; Kuhn JG; de Groot JF; Colman H; Ligon KL; Wen PY; Cloughesy TF; Mellinghoff IK; Butowski NA; Taylor JW; Clarke JL; Chang SM; Berger MS; Molinaro AM; Maggiora GM; Peng S; Nasser S; Liang WS; Trent JM; Berens ME; Carpten JD; Craig DW; Prados MD
Clin Cancer Res; 2018 Jan; 24(2):295-305. PubMed ID: 29074604
[No Abstract] [Full Text] [Related]
3. Whole-genome and transcriptome analysis enhances precision cancer treatment options.
Pleasance E; Bohm A; Williamson LM; Nelson JMT; Shen Y; Bonakdar M; Titmuss E; Csizmok V; Wee K; Hosseinzadeh S; Grisdale CJ; Reisle C; Taylor GA; Lewis E; Jones MR; Bleile D; Sadeghi S; Zhang W; Davies A; Pellegrini B; Wong T; Bowlby R; Chan SK; Mungall KL; Chuah E; Mungall AJ; Moore RA; Zhao Y; Deol B; Fisic A; Fok A; Regier DA; Weymann D; Schaeffer DF; Young S; Yip S; Schrader K; Levasseur N; Taylor SK; Feng X; Tinker A; Savage KJ; Chia S; Gelmon K; Sun S; Lim H; Renouf DJ; Jones SJM; Marra MA; Laskin J
Ann Oncol; 2022 Sep; 33(9):939-949. PubMed ID: 35691590
[TBL] [Abstract][Full Text] [Related]
4. Copenhagen Prospective Personalized Oncology (CoPPO)-Clinical Utility of Using Molecular Profiling to Select Patients to Phase I Trials.
Tuxen IV; Rohrberg KS; Oestrup O; Ahlborn LB; Schmidt AY; Spanggaard I; Hasselby JP; Santoni-Rugiu E; Yde CW; Mau-Sørensen M; Nielsen FC; Lassen U
Clin Cancer Res; 2019 Feb; 25(4):1239-1247. PubMed ID: 30274980
[TBL] [Abstract][Full Text] [Related]
5. Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers.
Khater F; Vairy S; Langlois S; Dumoucel S; Sontag T; St-Onge P; Bittencourt H; Dal Soglio D; Champagne J; Duval M; Leclerc JM; Laverdiere C; Tran TH; Patey N; Ellezam B; Perreault S; Piché N; Samson Y; Teira P; Jabado N; Michon B; Brossard J; Marzouki M; Cellot S; Sinnett D
JAMA Netw Open; 2019 Apr; 2(4):e192906. PubMed ID: 31026031
[TBL] [Abstract][Full Text] [Related]
6. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
7. High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial.
Massard C; Michiels S; Ferté C; Le Deley MC; Lacroix L; Hollebecque A; Verlingue L; Ileana E; Rosellini S; Ammari S; Ngo-Camus M; Bahleda R; Gazzah A; Varga A; Postel-Vinay S; Loriot Y; Even C; Breuskin I; Auger N; Job B; De Baere T; Deschamps F; Vielh P; Scoazec JY; Lazar V; Richon C; Ribrag V; Deutsch E; Angevin E; Vassal G; Eggermont A; André F; Soria JC
Cancer Discov; 2017 Jun; 7(6):586-595. PubMed ID: 28365644
[TBL] [Abstract][Full Text] [Related]
8. Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors.
Koeppel F; Bobard A; Lefebvre C; Pedrero M; Deloger M; Boursin Y; Richon C; Chen-Min-Tao R; Robert G; Meurice G; Rouleau E; Michiels S; Massard C; Scoazec JY; Solary E; Soria JC; André F; Lacroix L
Cancer J; 2018; 24(4):153-162. PubMed ID: 30119077
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
[TBL] [Abstract][Full Text] [Related]
10. Precision oncology based on omics data: The NCT Heidelberg experience.
Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
[TBL] [Abstract][Full Text] [Related]
11. Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine.
Aguirre AJ; Nowak JA; Camarda ND; Moffitt RA; Ghazani AA; Hazar-Rethinam M; Raghavan S; Kim J; Brais LK; Ragon D; Welch MW; Reilly E; McCabe D; Marini L; Anderka K; Helvie K; Oliver N; Babic A; Da Silva A; Nadres B; Van Seventer EE; Shahzade HA; St Pierre JP; Burke KP; Clancy T; Cleary JM; Doyle LA; Jajoo K; McCleary NJ; Meyerhardt JA; Murphy JE; Ng K; Patel AK; Perez K; Rosenthal MH; Rubinson DA; Ryou M; Shapiro GI; Sicinska E; Silverman SG; Nagy RJ; Lanman RB; Knoerzer D; Welsch DJ; Yurgelun MB; Fuchs CS; Garraway LA; Getz G; Hornick JL; Johnson BE; Kulke MH; Mayer RJ; Miller JW; Shyn PB; Tuveson DA; Wagle N; Yeh JJ; Hahn WC; Corcoran RB; Carter SL; Wolpin BM
Cancer Discov; 2018 Sep; 8(9):1096-1111. PubMed ID: 29903880
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.
Summers RJ; Castellino SM; Porter CC; MacDonald TJ; Basu GD; Szelinger S; Bhasin MK; Cash T; Carter AB; Castellino RC; Fangusaro JR; Mitchell SG; Pauly MG; Pencheva B; Wechsler DS; Graham DK; Goldsmith KC
JCO Precis Oncol; 2022 Apr; 6():e2100451. PubMed ID: 35544730
[TBL] [Abstract][Full Text] [Related]
13. Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes.
San Lucas FA; Allenson K; Bernard V; Castillo J; Kim DU; Ellis K; Ehli EA; Davies GE; Petersen JL; Li D; Wolff R; Katz M; Varadhachary G; Wistuba I; Maitra A; Alvarez H
Ann Oncol; 2016 Apr; 27(4):635-41. PubMed ID: 26681674
[TBL] [Abstract][Full Text] [Related]
14. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
Grewal JK; Tessier-Cloutier B; Jones M; Gakkhar S; Ma Y; Moore R; Mungall AJ; Zhao Y; Taylor MD; Gelmon K; Lim H; Renouf D; Laskin J; Marra M; Yip S; Jones SJM
JAMA Netw Open; 2019 Apr; 2(4):e192597. PubMed ID: 31026023
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.
Cobain EF; Wu YM; Vats P; Chugh R; Worden F; Smith DC; Schuetze SM; Zalupski MM; Sahai V; Alva A; Schott AF; Caram MEV; Hayes DF; Stoffel EM; Jacobs MF; Kumar-Sinha C; Cao X; Wang R; Lucas D; Ning Y; Rabban E; Bell J; Camelo-Piragua S; Udager AM; Cieslik M; Lonigro RJ; Kunju LP; Robinson DR; Talpaz M; Chinnaiyan AM
JAMA Oncol; 2021 Apr; 7(4):525-533. PubMed ID: 33630025
[TBL] [Abstract][Full Text] [Related]
16. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan.
Kikuchi J; Ohhara Y; Takada K; Tanabe H; Hatanaka K; Amano T; C Hatanaka K; Hatanaka Y; Mitamura T; Kato M; Shibata Y; Yabe I; Endoh A; Komatsu Y; Matsuno Y; Sugiyama M; Manabe A; Sakurai A; Takahashi M; Naruse H; Torimoto Y; Dosaka-Akita H; Kinoshita I
Jpn J Clin Oncol; 2021 Apr; 51(5):753-761. PubMed ID: 33532831
[TBL] [Abstract][Full Text] [Related]
18. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
[TBL] [Abstract][Full Text] [Related]
19. Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.
Rodriguez-Rodriguez L; Hirshfield KM; Rojas V; DiPaola RS; Gibbon D; Hellmann M; Isani S; Leiser A; Riedlinger GM; Wagreich A; Ali SM; Elvin JA; Miller VA; Ganesan S
Gynecol Oncol; 2016 Apr; 141(1):2-9. PubMed ID: 27016222
[TBL] [Abstract][Full Text] [Related]
20. Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.
Langenberg KPS; Meister MT; Bakhuizen JJ; Boer JM; van Eijkelenburg NKA; Hulleman E; Ilan U; Looze EJ; Dierselhuis MP; van der Lugt J; Breunis W; Schild LG; Ober K; van Hooff SR; Scheijde-Vermeulen MA; Hiemcke-Jiwa LS; Flucke UE; Kranendonk MEG; Wesseling P; Sonneveld E; Punt S; Boltjes A; van Dijk F; Verwiel ETP; Volckmann R; Hehir-Kwa JY; Kester LA; Koudijs MMJ; Waanders E; Holstege FCP; Vormoor HJ; Hoving EW; van Noesel MM; Pieters R; Kool M; Stumpf M; Blattner-Johnson M; Balasubramanian GP; Van Tilburg CM; Jones BC; Jones DTW; Witt O; Pfister SM; Jongmans MCJ; Kuiper RP; de Krijger RR; Wijnen MHW; den Boer ML; Zwaan CM; Kemmeren P; Koster J; Tops BBJ; Goemans BF; Molenaar JJ
Eur J Cancer; 2022 Nov; 175():311-325. PubMed ID: 36182817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
